{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:36:56Z","timestamp":1784810216193,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuhan City Health and Family Planning Commission of clinical medical research major project","award":["No.WX19M03"],"award-info":[{"award-number":["No.WX19M03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The aim of this study was to find early predictors of Intravenous Immunoglobulin (IVIG)-Resistant Kawasaki Disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients diagnosed with Kawasaki disease were enrolled in this study. Univariate analysis and multiple logistic regression were used to analyze the clinical characteristics and laboratory findings of patients in both groups before IVIG treatment. Independent predictors of Intravenous Immunoglobulin-Resistant Kawasaki Disease were analyzed, and a prediction model for children with Intravenous Immunoglobulin-Resistant Kawasaki Disease was constructed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 108 children (67 males and 41 females) with IVIG-sensitive Kawasaki disease and 31 children (20 males and 11 females) with IVIG-resistant Kawasaki disease participated in this study. Compared with the IVIG-sensitive group, the duration of hospitalization, ALT, AST, GLB, r-GT, IgG, PCT, and ESR was elevated in the IVIG-resistant KD group, and ATG16L1, LC3II, BECN1, RBC, HGB, ALB, A\/G, and CK were significantly lower (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). mRNA expression of ESR, BECN1, and LC3II were independent risk factors for IVIG-resistant Kawasaki disease. A logistic regression model and scoring system were established, and the cut-off values of independent risk factors were derived from ROC curves: ESR\u2009\u2265\u200979.5\u00a0mm\/h, BECN1\u2009\u2264\u20090.645, LC3II\u2009\u2264\u20090.481. A new scoring system was established according to the respective regression coefficients as follows: ESR\u2009\u2265\u200979.5\u00a0mm\/h (1 point), BECN1\u2009\u2264\u20090.645 (1 point). LC3II\u2009\u2264\u20090.481 (2 points), 0\u20131 as low risk for IVIG non-response, and\u2009\u2265\u20092 as high risk. Applied to this group of study subjects, the sensitivity was 87.10%, specificity 83.33%, Youden index 0.70, AUC 0.9.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Autophagy markers ATG16L1, BECN1, and LC3II are down-regulated in the expression of IVIG -resistant KD. ESR, BECN1, and LC3II mRNAs are independent risk factors for IVIG-resistant KD and may be involved in the development of IVIG-resistant KD. This study established a new model that can be used to predict IVIG-resistant KD, and future validation in a larger population is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-023-04386-3","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T04:02:32Z","timestamp":1702958552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model"],"prefix":"10.1186","volume":"23","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"3","key":"4386_CR1","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16(3):178\u2013222.","journal-title":"Arerugi"},{"issue":"3","key":"4386_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2188\/jea.JE20140089","volume":"25","author":"N Makino","year":"2015","unstructured":"Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H. Descriptive epidemiology of Kawasaki disease in Japan, 2011\u20132012: from the results of the 22nd nationwide survey. J Epidemiol. 2015;25(3):239\u201345.","journal-title":"J Epidemiol"},{"issue":"4","key":"4386_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ped.13809","volume":"61","author":"N Makino","year":"2019","unstructured":"Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R, Aoyama Y, Yanagawa H. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015\u20132016. Pediatr Int. 2019;61(4):397\u2013403.","journal-title":"Pediatr Int"},{"issue":"3","key":"4386_CR4","first-page":"213","volume":"23","author":"ZL Mu","year":"2021","unstructured":"Mu ZL, Jiao FY, Xie KS. Interpretation of the JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(3):213\u201320.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"10","key":"4386_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2188\/jea.JE20190065","volume":"30","author":"LP Xie","year":"2020","unstructured":"Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F. Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol. 2020;30(10):429\u201335.","journal-title":"J Epidemiol"},{"key":"4386_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the Nationwide Survey in Japan, 2017\u20132018. J Pediatr. 2020;225:23-29.e22.","journal-title":"J Pediatr"},{"issue":"17","key":"4386_CR7","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"4","key":"4386_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/art.42041","volume":"74","author":"M Gorelik","year":"2022","unstructured":"Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, et al. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis Rheumatol. 2022;74(4):586\u201396.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"4386_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3345\/kjp.2017.60.7.208","volume":"60","author":"SJ Kang","year":"2017","unstructured":"Kang SJ, Kim NS. Association of Toll-like receptor 2-positive monocytes with coronary artery lesions and treatment nonresponse in Kawasaki disease. Korean J Pediatr. 2017;60(7):208\u201315.","journal-title":"Korean J Pediatr"},{"key":"4386_CR10","doi-asserted-by":"crossref","unstructured":"Tulloh RMR, Mayon-White R, Harnden A. Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015. Arch Dis Child. 2019;104(7):640\u20136.","DOI":"10.1136\/archdischild-2018-315087"},{"issue":"22","key":"4386_CR11","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606\u201312.","journal-title":"Circulation"},{"issue":"3","key":"4386_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/archdischild-2017-314512","volume":"104","author":"S Yang","year":"2019","unstructured":"Yang S, Song R, Zhang J, Li X, Li C. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child. 2019;104(3):262\u20137.","journal-title":"Arch Dis Child"},{"issue":"3","key":"4386_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313\u201326.","journal-title":"Cell"},{"issue":"2","key":"4386_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cyto.2011.08.022","volume":"56","author":"J Harris","year":"2011","unstructured":"Harris J. Autophagy and cytokines. Cytokine. 2011;56(2):140\u20134.","journal-title":"Cytokine"},{"issue":"11","key":"4386_CR15","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","volume":"286","author":"J Harris","year":"2011","unstructured":"Harris J, Hartman M, Roche C, Zeng SG, O\u2019Shea A, Sharp FA, Lambe EM, Creagh EM, Golenbock DT, Tschopp J, et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 2011;286(11):9587\u201397.","journal-title":"J Biol Chem"},{"key":"4386_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12950-019-0212-4","volume":"16","author":"M Hassanpour","year":"2019","unstructured":"Hassanpour M, Rahbarghazi R, Nouri M, Aghamohammadzadeh N, Safaei N, Ahmadi M. Role of autophagy in atherosclerosis: foe or friend? J Inflamm (Lond). 2019;16:8.","journal-title":"J Inflamm (Lond)"},{"issue":"18","key":"4386_CR17","doi-asserted-by":"publisher","first-page":"e151981","DOI":"10.1172\/jci.insight.151981","volume":"6","author":"S Marek-Iannucci","year":"2021","unstructured":"Marek-Iannucci S, Ozdemir AB, Moreira D, Gomez AC, Lane M, Porritt RA, Lee Y, Shimada K, Abe M, Stotland A, et al. Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis. JCI Insight. 2021;6(18):e151981.","journal-title":"JCI Insight"},{"issue":"10","key":"4386_CR18","first-page":"166","volume":"7","author":"FC Huang","year":"2020","unstructured":"Huang FC, Huang YH, Kuo HC, Li SC. Identifying downregulation of autophagy markers in Kawasaki disease. Children (Basel). 2020;7(10):166.","journal-title":"Children (Basel)"},{"issue":"10","key":"4386_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","volume":"22","author":"E Rife","year":"2020","unstructured":"Rife E, Gedalia A. Kawasaki disease: an update. Curr Rheumatol Rep. 2020;22(10):75.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"4386_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang C, Livingston MJ, Liu Z, Dong Z. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020;16(9):489\u2013508.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"4386_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/ars.2013.5371","volume":"20","author":"KR Parzych","year":"2014","unstructured":"Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014;20(3):460\u201373.","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"4386_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ni.3025","volume":"15","author":"X Xu","year":"2014","unstructured":"Xu X, Araki K, Li S, Han JH, Ye L, Tan WG, Konieczny BT, Bruinsma MW, Martinez J, Pearce EL, et al. Autophagy is essential for effector CD8(+) T cell survival and memory formation. Nat Immunol. 2014;15(12):1152\u201361.","journal-title":"Nat Immunol"},{"issue":"6","key":"4386_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chom.2009.05.016","volume":"5","author":"V Deretic","year":"2009","unstructured":"Deretic V, Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe. 2009;5(6):527\u201349.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"4386_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/MOH.0000000000000138","volume":"22","author":"A Zecchin","year":"2015","unstructured":"Zecchin A, Borgers G, Carmeliet P. Endothelial cells and cancer cells: metabolic partners in crime? Curr Opin Hematol. 2015;22(3):234\u201342.","journal-title":"Curr Opin Hematol"},{"key":"4386_CR25","doi-asserted-by":"crossref","unstructured":"Wang J, Wang WN, Xu SB. MicroRNA-214-3p: A link between autophagy and endothelial cell dysfunction in atherosclerosis. Acta Physiol (Oxf). 2018;222(3).","DOI":"10.1111\/apha.12973"},{"issue":"16","key":"4386_CR26","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMra2022774","volume":"383","author":"N Mizushima","year":"2020","unstructured":"Mizushima N, Levine B. Autophagy in human diseases. N Engl J Med. 2020;383(16):1564\u201376.","journal-title":"N Engl J Med"},{"issue":"40","key":"4386_CR27","doi-asserted-by":"publisher","first-page":"29776","DOI":"10.1074\/jbc.M603783200","volume":"281","author":"A Hamacher-Brady","year":"2006","unstructured":"Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia\/reperfusion injury in cardiac myocytes. J Biol Chem. 2006;281(40):29776\u201387.","journal-title":"J Biol Chem"},{"issue":"39","key":"4386_CR28","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1073\/pnas.0506843102","volume":"102","author":"L Yan","year":"2005","unstructured":"Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang G, Matsui Y, Sadoshima J, Vatner SF. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005;102(39):13807\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"4386_CR29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.febslet.2013.04.025","volume":"587","author":"E Zavodszky","year":"2013","unstructured":"Zavodszky E, Vicinanza M, Rubinsztein DC. Biology and trafficking of ATG9 and ATG16L1, two proteins that regulate autophagosome formation. FEBS Lett. 2013;587(13):1988\u201396.","journal-title":"FEBS Lett"},{"key":"4386_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-981-15-0602-4_5","volume":"1206","author":"HD Xu","year":"2019","unstructured":"Xu HD, Qin ZH. Beclin 1, Bcl-2 and Autophagy. Adv Exp Med Biol. 2019;1206:109\u201326.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"4386_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.semcancer.2013.05.007","volume":"23","author":"M Wirth","year":"2013","unstructured":"Wirth M, Joachim J, Tooze SA. Autophagosome formation\u2013the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 2013;23(5):301\u20139.","journal-title":"Semin Cancer Biol"},{"key":"4386_CR32","doi-asserted-by":"publisher","first-page":"876147","DOI":"10.3389\/fcell.2022.876147","volume":"10","author":"M Sano","year":"2022","unstructured":"Sano M, Maejima Y, Nakagama S, Shiheido-Watanabe Y, Tamura N, Hirao K, Isobe M, Sasano T. Neutrophil extracellular traps-mediated Beclin-1 suppression aggravates atherosclerosis by inhibiting macrophage autophagy. Front Cell Dev Biol. 2022;10:876147.","journal-title":"Front Cell Dev Biol"},{"issue":"20","key":"4386_CR33","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1161\/CIRCULATIONAHA.117.032821","volume":"138","author":"Y Sun","year":"2018","unstructured":"Sun Y, Yao X, Zhang QJ, Zhu M, Liu ZP, Ci B, Xie Y, Carlson D, Rothermel BA, Sun Y, et al. Beclin-1-dependent autophagy protects the heart during sepsis. Circulation. 2018;138(20):2247\u201362.","journal-title":"Circulation"},{"issue":"2","key":"4386_CR34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s10753-018-00952-5","volume":"42","author":"H Zhao","year":"2019","unstructured":"Zhao H, Chen H, Xiaoyin M, Yang G, Hu Y, Xie K, Yu Y. Autophagy activation improves lung injury and inflammation in sepsis. Inflammation. 2019;42(2):426\u201339.","journal-title":"Inflammation"},{"issue":"4","key":"4386_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/SHK.0000000000001040","volume":"50","author":"T Oami","year":"2018","unstructured":"Oami T, Watanabe E, Hatano M, Teratake Y, Fujimura L, Sakamoto A, Ito C, Toshimori K, Swanson PE, Oda S. Blocking liver autophagy accelerates apoptosis and mitochondrial injury in hepatocytes and reduces time to mortality in a murine sepsis model. Shock. 2018;50(4):427\u201334.","journal-title":"Shock"},{"key":"4386_CR36","unstructured":"\u94b1\u6625\u745c: \u8840\u6e05\u94c1\u86cb\u767d\u68c0\u6d4b\u5728\u5c0f\u513f\u5ddd\u5d0e\u75c5\u4e2d\u7684\u5e94\u7528\u4ef7\u503c\u5206\u6790. \u4e34\u5e8a\u533b\u836f\u6587\u732e\u7535\u5b50\u6742\u5fd7 2018;5(81):93\u201394."},{"key":"4386_CR37","doi-asserted-by":"publisher","first-page":"953730","DOI":"10.3389\/fimmu.2022.953730","volume":"13","author":"H Tsuboi","year":"2022","unstructured":"Tsuboi H, Segawa S, Yagishita M, Toko H, Honda F, Kitada A, Miki H, Ohyama A, Hagiwara S, Kondo Y, et al. Activation mechanisms of monocytes\/macrophages in adult-onset Still disease. Front Immunol. 2022;13:953730.","journal-title":"Front Immunol"},{"key":"4386_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E. LC3 and autophagy. Methods Mol Biol. 2008;445:77\u201388.","journal-title":"Methods Mol Biol"},{"key":"4386_CR39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.biopha.2017.11.083","volume":"96","author":"X Xiong","year":"2017","unstructured":"Xiong X, Ren Y, Cui Y, Li R, Wang C, Zhang Y. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. Biomed Pharmacother. 2017;96:1292\u20138.","journal-title":"Biomed Pharmacother"},{"key":"4386_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.05.016","volume":"145","author":"Q Fei","year":"2020","unstructured":"Fei Q, Ma H, Zou J, Wang W, Zhu L, Deng H, Meng M, Tan S, Zhang H, Xiao X, et al. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J Mol Cell Cardiol. 2020;145:1\u201313.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4386_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40360-016-0109-2","volume":"18","author":"FC Huang","year":"2017","unstructured":"Huang FC, Kuo HC, Huang YH, Yu HR, Li SC, Kuo HC. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. BMC Pharmacol Toxicol. 2017;18(1):3.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"8","key":"4386_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00431-018-3182-2","volume":"177","author":"X Li","year":"2018","unstructured":"Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr. 2018;177(8):1279\u201392.","journal-title":"Eur J Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04386-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T16:33:40Z","timestamp":1703003620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04386-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4386"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04386-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2991849\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Wuhan Children\u2019s Hospital Ethics Committee. Written informed consent was obtained from all participants in the study. All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all subjects or, if subjects are under 18, from a parent and\/or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"642"}}